Trial Profile
Title A Pilot Trial to Evaluate Syndros in Decreasing Opioid Requirement in Patients With Bone Metastases From Breast Cancer
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 10 Feb 2023
Price :
$35
*
At a glance
- Drugs Dronabinol (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- 27 Apr 2021 Status changed from active, no longer recruiting to completed.
- 15 Feb 2021 Planned End Date changed from 30 Dec 2020 to 30 Dec 2021.
- 15 Feb 2021 Planned primary completion date changed from 30 Dec 2020 to 30 Dec 2021.